ravimaine h2 receptor antagonist in combination with a proton pump inhibitor or a pharmaceutical composition, and use for the treatment of gastric intestinal disorders

摘要

The invention relates to methods and compositions for the prevention, treatment, or management of gastrointestinal disorders or symptoms thereof, employing two or more agents or compounds to provide a triple site action on 5-HT3 receptors, 5-HT4 receptors, and at least one of H2 receptors and proton pumps.